1. Effective bladder preservation strategy with low-dose radiation therapy and concurrent intraarterial chemotherapy for muscle-invasive bladder cancer.
- Author
-
Ikushima H, Iwamoto S, Osaki K, Furutani S, Yamashita K, Kawanaka T, Kubo A, Takegawa Y, Kudoh T, Kanayama H, and Nishitani H
- Subjects
- Combined Modality Therapy, Cystectomy, Female, Humans, Infusions, Intra-Arterial, Male, Neoplasm Invasiveness, Neoplasm Recurrence, Local, Radiotherapy Dosage, Retrospective Studies, Survival Rate, Treatment Outcome, Urinary Bladder Neoplasms pathology, Urinary Bladder Neoplasms surgery, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Urinary Bladder Neoplasms drug therapy, Urinary Bladder Neoplasms radiotherapy
- Abstract
Purpose: The aim of this study was to evaluate retrospectively the toxicity and response, bladder preservation, and survival of patients with muscle-invasive bladder cancer treated with multimodality therapy consisting of low-dose radiation therapy (RT) and concurrent intraarterial chemotherapy (IACT)., Methods and Materials: . Between November 1999 and July 2005, a total of 27 consecutive, previously untreated patients with muscle-invasive bladder cancer underwent transurethral bladder tumor resection followed by concurrent low-dose RT and IACT. Patients who achieved a complete response (CR) were followed up closely without further therapy, and patients who did not achieve a CR underwent further treatment., Results: Complete response was achieved in 22 of 27 patients (81%). Of these 22 patients, 7 developed recurrences, and 3 died of their disease. In five patients who did not achieve CR, one died from bone metastases. The 3-year overall survival rate was 81%, with a median follow-up time of 27 months; and 22 of 27 patients (81%) with a preserved bladder were tumor-free at the last follow-up. Three patients (11%) developed grade 3 acute hematological toxicity., Conclusion: Multimodality therapy consisting of low-dose RT and concurrent IACT for muscle-invasive bladder cancer can achieve survival rates similar to those in patients treated with radical cystectomy, with successful bladder preservation and minimal adverse effects.
- Published
- 2008
- Full Text
- View/download PDF